MACROGOL 3350
Adenomatous Polyp
National Cancer Institute (NCI)OtherPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Adenomatous Polyp cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Acetylsalicylic Acid National Cancer Institute (NCI) | Phase 3 | BB |
MARBLE DUST Colotech A/S | Phase 3 | BB |
PEG-Ascorbate Korea University Anam Hospital | Phase 3 | BB |
Spmc 2 Korea University Anam Hospital | Phase 3 | BB |
SODIUM PICOSULFATE HYDRATE Korea University Anam Hospital | Phase 3 | BB |
View all 17 →
Same molecule, other indications
MACROGOL 3350 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →